| Literature DB >> 25562025 |
Zohreh Jaafari Ashkavandi1, Zahra Ahmadi Sheshdeh1, Fereshteh Kamali1.
Abstract
OBJECTIVE: Oral and maxillofacial lesions vary regarding their clinical presentation in different populations. Until now, oral and maxillofacial lesions in Iranian children and adolescents have not been studied. The aim of this study was to determine the type and distribution of biopsied oral lesions among children and adolescents in Southern Iran.Entities:
Keywords: Pathologic Lesion; Oral Pathology; Maxillofacial Malignancy
Year: 2014 PMID: 25562025 PMCID: PMC4276586
Source DB: PubMed Journal: Iran J Pediatr ISSN: 2008-2142 Impact factor: 0.364
Soft tissue lesions
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
| |||||
|
| 76 | 16 | 35/1 | 2 | Gingiva | |
|
| 33 | 34 | 24/8 | 1 | Gingiva | |
|
| 9 | 32 | 16/4 | 1/1 | Gingiva | |
|
| 7 | 15 | 8/4 | 0/6 | Gingiva | |
|
| 8 | 9 | 6/5 | 0/5 | Gingiva | |
|
| 4 | 6 | 3/8 | 4 | Buccal mucosa | |
|
| 2 | 3 | 2 | 1/5 | Gingiva | |
|
| 2 | 1 | 1/2 | 0:3 | Gingiva | |
|
| 3 | - | 1/2 | 0:3 | Buccal mucosa | |
|
| 2 | - | 0/8 | 1 | Gingiva | |
|
| 146 | 116 | - | - | ||
Odontogenic cysts and tumors
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
|
| ||||
|
| 53 | 29 | 71/4 | 2/03 | Mand |
|
| 6 | 20 | 22/6 | 1/16 | Max = Mand |
|
| 6 | 0 | 5/2 | 6:0 | Mand |
|
| 0 | 1 | 0/8 | 0:1 | Max |
|
| 4 | 5 | 27/3 | 2 | Max |
|
| 1 | 8 | 27/3 | 1/25 | Mand |
|
| - | 5 | 15/2 | 0/25 | Mand |
|
| 1 | 3 | 12/2 | 1 | Max |
|
| - | 3 | 9 | 0/5 | Mand |
|
| 2 | - | 6 | 0:2 | Max = Mand |
|
| 1 | - | 3 | 1:0 | Mand |
|
| 74 | 74 | |||
KOT: Keratocystic odontogenic tumor; AOT: Adenomatoid odontogenic cyst
Salivary gland disease and epithelial pathology and hematologic disorders
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
|
| ||||
|
| 20 | 25 | 93/7 | 1/5 | Lower lip & |
| Floor of mouth | |||||
|
| - | 2 | 4 | 1 | Parotid |
|
| 1 | - | 2 | 1:0 | Palate |
|
| 1 | - | 2 | 1:0 | Palate |
|
| 1 | - | 2 | 0:1 | Parotid |
|
| 3 | 4 | 53/5 | 1/3 | Gingiva |
|
| 2 | 3 | 39 | 0:5 | Lip and tongue |
|
| - | 1 | 7/5 | 0:1 | Buccal mucosa |
|
| 4 | 1 | 71/5 | 5:0 | Vestibule |
|
| - | 2 | 28/5 | 1 | Mand = Max |
|
| 32 | 38 | - | - | - |
Pulp and periapical diseases and bone pathology
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
|
| ||||
|
| 15 | 18 | 91/7 | 1/3 | Max |
|
| 1 | 2 | 8/3 | 2 | Mand |
|
| 16 | 11 | 45 | 0/7 | Mand |
|
| 2 | 7 | 15 | 1 | Max |
|
| 3 | 5 | 13/3 | 1 | Max |
|
| 3 | 4 | 11/7 | 0:7 | Mand |
|
| 0 | 6 | 10 | 1 | Mand |
|
| 1 | 1 | 3/4 | 1 | Max |
|
| 0 | 1 | 1/6 | 0:1 | Max |
|
| 41 | 55 | |||
CGCG: central giant cell granuloma